RE:RE:RE:RE:RE:RE:Agoracom is a good pick. The people who will most likely buy into the various price plans of AnalyticsGPT are already using it in the trials, and other clients will be drawn in by the reviews from those companies who complete the trials and continue to use / buy after full launch. As mentioned earlier, this will then be the right time to launch a massive marketing campaign.
I do not need any help reading financial statements. Maybe you need help doing due diligence on your investments. I have held DM for 4 years now and continue to hold because I have faith in the new verticals that were wisely established using COVID cash, and I recognize that new verticals take time and money to grow and become profitable. Cash from the Canadian government deal alone can keep them afloat for another couple years even if all other verticals brought in nothing in that timeframe.
However that won't be the case as revs from AnalyticsGPT will be coming in by Q3 of this year.
DM EVS will have increasing revs as they continue to expand and bring more charging stations online (holiday inn deal, others at commercial/condo properties in Vancouver, new Toronto location, etc) and mobile charging.
Medi-Call had 432 subscribers at end of Q1, with contracts for international student agencies still to be completed in Q3 which will see a big boost to subscribers. Each Imagine Health Clinic has annual revs of approx 2.5M, with two already operational and two more clinics coming, Clinic Revs alone will double from $5M to $10M annually (assuming same numbers, however they will likely
increase with new services being offered). *Yes I know this division is going to be spun-off, however DM will still be in a position to profit off of those shares*.
Not sure why you are holding any DM shares at all if you do
not see a future for the new verticals, deal with the growing pains and quit the whining.